Literature DB >> 2270300

Women's use of information regarding hormone replacement therapy.

M Rothert1, D Rovner, M Holmes, N Schmitt, G Talarczyk, J Kroll, J Gogate.   

Abstract

For perimenopausal women, an important decision is whether or not to use hormone replacement therapy (HRT). The decision is complex because HRT involves judgment in weighing gains and losses related to physiological risk. Gains involve relief of hot flashes and prevention of osteoporosis; losses include cancer mortality and side effects of medication. A policy-capturing study of 283 perimenopausal women showed that the factor of most frequent concern was relief of hot flashes. Cluster analyses identified four major groups. Group 4 had an n of 9 and the lowest R2, making interpretation of data questionable. The largest group responded to hot flashes alone; the second to hot flashes and osteoporosis; and the third to hot flashes, somewhat to osteoporosis, but also to side effects of estrogen/progestin therapy. Results indicate nursing interventions should anticipate differences in women's concerns and tailor counseling appropriately.

Entities:  

Mesh:

Year:  1990        PMID: 2270300     DOI: 10.1002/nur.4770130603

Source DB:  PubMed          Journal:  Res Nurs Health        ISSN: 0160-6891            Impact factor:   2.228


  4 in total

1.  Initiation and discontinuation of hormone therapy for menopausal symptoms: results from a community sample.

Authors:  Hayden B Bosworth; Lori A Bastian; Steven C Grambow; Colleen M McBride; Celette Sugg Skinner; Laura Fish; Barbara K Rimer; Ilene C Siegler
Journal:  J Behav Med       Date:  2005-02

2.  Risks and benefits of coronary angioplasty: the patients perspective: a preliminary study.

Authors:  F Kee; P McDonald; B Gaffney
Journal:  Qual Health Care       Date:  1997-09

Review 3.  A systematic review of information in decision aids.

Authors:  Deb Feldman-Stewart; Sarah Brennenstuhl; Kathryn McIssac; Joan Austoker; Agathe Charvet; Paul Hewitson; Karen R Sepucha; Tim Whelan
Journal:  Health Expect       Date:  2007-03       Impact factor: 3.377

4.  [Factors influencing the adoption of hormone replacement therapy].

Authors:  F Légaré; S Dodin; G Godin
Journal:  Can Fam Physician       Date:  1998-06       Impact factor: 3.275

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.